July 16, 2018 Price forecast | 2 weeks: 0.17% | 1 month: 0.57% | 3 months: 1.27%


PFE stock forecast

Our latest prediction for Pfizer Inc.'s stock price was made on the July 16, 2018 when the stock price was at 37.38$.

In the short term (2weeks), PFE's stock price should outperform the market by 0.17%. During that period the price should oscillate between -2.38% and +2.36%.

In the medium term (3months), PFE's stock price should outperform the market by 1.27%. During that period the price should oscillate between -5.71% and +7.76%.


About Pfizer Inc.

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

At the moment the company generates 53859M USD in revenues.

On its last earning announcement, the company reported a profit of 1.96$ per share.

The book value per share is 11.90$

Pfizer Inc. website


Three months stock forecastJuly 16, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
53859M 79.40% 15513M 28.80% 11476M 1.96 1.38 35.20% 5900M 11.90 15542M -2396M 13146M